comparemela.com

Latest Breaking News On - Values first advisors - Page 9 : comparemela.com

AcelRx Pharmaceuticals (NASDAQ:ACRX) Earns Sell Rating from Analysts at StockNews com

AcelRx Pharmaceuticals (NASDAQ:ACRX) Earns Sell Rating from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Costello Asset Management INC Has $770,000 Stake in CrowdStrike Holdings, Inc (NASDAQ:CRWD)

Costello Asset Management INC cut its stake in CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) by 28.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,600 shares of the company’s stock after selling 1,820 shares during the period. Costello […]

Values First Advisors Inc Has $363,000 Position in STERIS plc (NYSE:STE)

Values First Advisors Inc Has $363,000 Position in STERIS plc (NYSE:STE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Values First Advisors Inc Acquires 37,444 Shares of Under Armour, Inc (NYSE:UA)

Values First Advisors Inc. increased its position in shares of Under Armour, Inc. (NYSE:UA – Free Report) by 84.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 81,833 shares of the company’s stock after buying an additional 37,444 shares during the quarter. Values […]

AcelRx Pharmaceuticals (NASDAQ:ACRX) Research Coverage Started at StockNews com

StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other analysts have also recently commented on ACRX. Alliance Global Partners began coverage on AcelRx Pharmaceuticals in a report on Monday, October […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.